FierceBiotech @FierceBiotech · 29 Aug 2026
@FierceBiotech New modalities only reach patients if there are people who can take them from bench to GMP production. On ATMP growth in the Netherlands and the talent it demands: https://t.co/gnLFZOKcZo
24Views
0Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
0.03×vs this author's median796 views is typical
0Percentile for this authorof 7 recent posts
0.02%Reachviews ÷ followers
0.00%Engagement rateof viewers reacted